Current challenges in the discovery of treatments against Mayaro fever.
Antiviral compounds
arthritogenic disease
candidate treatments
compound screening technologies
immunopathogenesis
infection models
mayaro virus
Journal
Expert opinion on therapeutic targets
ISSN: 1744-7631
Titre abrégé: Expert Opin Ther Targets
Pays: England
ID NLM: 101127833
Informations de publication
Date de publication:
08 May 2024
08 May 2024
Historique:
pubmed:
8
5
2024
medline:
8
5
2024
entrez:
7
5
2024
Statut:
aheadofprint
Résumé
Mayaro fever is an emerging viral disease that manifests as an acute febrile illness. The disease is self-limiting, however joint pain can persist for months leading to chronic arthralgia. There is no specific treatment available, which ultimately leads to socioeconomic losses in populations at risk as well as strains to the public health systems. We reviewed the candidate treatments proposed for Mayaro virus (MAYV) infection and disease, including antiviral compounds targeting viral or host mechanisms, and pathways involved in disease development and pathogenicity. We assessed compound screening technologies and experimental infection models used in these studies and indicated the advantages and limitations of available technologies and intended therapeutic strategies. Although several compounds have been suggested as candidate treatments against MAYV infection, notably those with antiviral activity, most compounds were assessed only
Identifiants
pubmed: 38714500
doi: 10.1080/14728222.2024.2351504
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM